EMJARD MXR 25/1000MG TAB

EMJARD MXR 25/1000MG is a combination tablet containing Empagliflozin and Metformin. This dual-action formulation is designed to help manage type 2 diabetes by improving blood sugar control through two complementary mechanisms. Empagliflozin works by increasing glucose excretion through urine, while Metformin reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation provides sustained therapeutic effect throughout the day. Suitable for patients requiring combination therapy to achieve optimal glycemic control. Always use as directed by your healthcare provider.